Full-Time
Customer Experience Specialist
Posted on 9/18/2025
AgelessRx
51-200 employees
Direct-to-consumer telehealth for longevity treatments
Compensation Overview
$55k/yr
Remote in USA
Remote
 Customer Experience & Support (1) |
|---|
- Minimum 2 years in a client facing role
- Education and/or professional experience in health, wellness, or a related field
- Excellent verbal and written communication skills
- Excellent organizational skills and exceptional attention to detail
- Strong problem-solving skills
- Ability to work both independently and as a member of a team
- Ability to manage time effectively while handling multiple tasks
- Ability to work consistently between the hours of 8am and 5pm EST, Monday through Friday
- Interest in the anti-aging/longevity movement
- Become an AgelessRx product expert by supporting and educating customers on their longevity journey
- Complete additional subject matter expertise training, as assigned
- Answer prospective and current patient inquiries timely, efficiently, and thoroughly to maximize satisfaction
- Assist patients in achieving successful outcomes by obtaining feedback, providing advanced product/service support, and/or partnering with medical providers
- Proactively identify patient inquiries that require clinical and/or provider insight, and escalate accordingly
- Assist with developing and improving the customer experience infrastructure
- Help develop and improve company processes and internal CX efficiency
- Partner with pharmacy partners and necessary vendors to ensure prescriptions and/or services are delivered on time
- Assist with updating patient medical records, as needed
- Provide administrative support for various medical initiatives, including small clinical trials
AgelessRx offers telehealth-based longevity care, providing access to prescription medications and therapies aimed at slowing aging and preventing age-related diseases. Its products include Metformin, Low Dose Naltrexone (LDN), NAD+ patches, and Galleri cancer screening, all available through a direct-to-consumer subscription model. Customers complete online consultations with healthcare professionals, receive prescriptions, and have treatments delivered to their homes. The company differentiates itself with science-backed treatment options, educational resources, and a portion of profits directed toward longevity research and advocacy, positioning itself to serve consumers seeking proactive health management. Its goal is to help people extend their healthspan by making preventative anti-aging care more accessible and by supporting scientific progress in longevity.
Company Size
51-200
Company Stage
N/A
Total Funding
$1
Headquarters
Ann Arbor, Michigan
Founded
2019
Simplify's Take
What believers are saying
- 6,600 patients gained mental clarity; 8,300 boosted energy in 2025.
- 5,200+ completed clinical studies on therapy efficacy.
- 82.7% reported improvements by first check-in.
What critics are saying
- FDA halts GLP-1 microdosing trial for unapproved anti-aging use.
- Novo Nordisk undercuts prices, captures market in 18 months.
- Adverse events from Rapamycin trigger lawsuits in 12 months.
What makes AgelessRx unique
- Offers Rapamycin and microdosed GLP-1s via Stanford PhD-led trials.
- Infinite Longevity Support targets all 9 aging hallmarks.
- Provides 30+ diagnostics including NAD+ Nasal Spray.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at AgelessRx who can refer or advise you
Benefits
Flexible Work Hours
Remote Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 3%2 year growth
↑ 7%In brief The research showed that biological age can be a stronger predictor of dementia risk than chronological age.According to a February 2025 report by the National Institutes of Health, more than 6 million Americans are living with dementia.Experts say tracking biological age helps improve the understanding of health and aging, while also identifying early risks of diseases such as dementia.Decrypt’s Art, Fashion, and Entertainment Hub. Discover SCENEAging faster on the inside—even if you're still young on the outside—could raise your risk of dementia, a new study from Zhengzhou University in China found.The research showed that biological age, or how well the body is functioning, can be a stronger predictor of dementia risk than chronological age.The study, published on Wednesday in Neurology, the journal of the American Academy of Neurology, used data from the UK Biobank and tracked 280,918 people with an average age of 57 over a 14-year period.It found that faster biological aging was linked to a 14% to 15% higher risk of developing dementia.“With the rising impact of dementia around the world, identifying risk factors and implementing preventive measures is essential,” lead researcher Dr. Yacong Bo said. “While none of us can change our chronological age, we can influence our biological age through lifestyle factors such as diet and exercise.”To assess biological aging, Chinese researchers used two metrics: Klemera–Doubal Method Biological Age (KDM-BA), which uses blood test results; and PhenoAge, which draws on clinical data tied to aging and mortality.For each increase in the rate of biological aging, as measured by KDM-BA and PhenoAge, the risk of dementia rose."These brain structure changes explain some, but not all, of the association between advanced biological age and dementia," Bo continued. "These results support the hypothesis that advanced biological age may contribute to the development of dementia by causing a widespread change in brain structures."More than 6 million Americans are living with dementia, which causes about 100,000 deaths annually, according to a February 2025 report by the National Institutes of Health.While dementia has declined 13% per decade due to better education, heart health, and lifestyle, the total number of cases is rising as the population ages, increasing pressure on the healthcare system.In 2020, the number of people worldwide with dementia stood at 55 million, according to the non-profit Alzheimer’s Disease International. By 2030, the number is expected to reach 78 million, and by 2050, it is projected to reach 139 million.Age is often seen as just a number on a calendar, with chronological age referring to the number of years one has been alive